Impact of Virtual Reality on Peri-interventional Pain, Anxiety and Distress in a Pediatric Oncology Outpatient Clinic

February 9, 2024 updated by: Hannover Medical School

Impact of Virtual Reality on Peri-interventional Pain, Anxiety and Distress in a Pediatric Oncology Outpatient Clinic: a Randomized Controlled Trial

Pain and anxiety-inducing interventions have a major impact on pediatric patients. Pain reduction by virtual reality (VR) during port and vein punctures is well studied. This study investigates peri-interventional reduction of pain, anxiety and distress using VR compared to the standard of care (SOC) in a pediatric oncology outpatient clinic.

In a randomized, controlled cross-over design, patients aged 6-18 years experience potentially painful interventions accompanied by VR. All patients included in the study underwent port puncture or peripheral venous puncture in two observations : SOC (A) and VR (B) in a randomized order. Observational instruments include Numeral Rating Scale (NRS), Faces Pain Scale revised (FPS-r), Behavioral Approach Avoidance Distress Scale (BAADS), modified Yale Preoperative Anxiety Scale (mYPAS-SF). In addition, parents and staff are interviewed. Specific conditions for VR in an outpatient clinic setting are being discussed.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lower Saxony
      • Hanover, Lower Saxony, Germany, 30625
        • Medical School Hanover

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • aged 6-18 years
  • any sex
  • port puncture or placement of a peripheral venous catheter in pediatric outpatient clinic
  • hematological or oncological diagnosis
  • informed consent

Exclusion Criteria:

  • epilepsy
  • coronary artery disease
  • history of severe vertigo
  • obstacles to putting on and wearing VR glasses
  • lack of informed consent for study participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: SOC (A)
SOC = Standard-of-Care
Experimental: VR (B)
VR = Virtual Reality
Virtual Reality was used before and during punctures. For every observation patients underwent either port puncture or peripheral venous puncture. One examination was carried out according to the Standard-of-Care. The other one was carried out with the additional use of VR. Participants watched a passive distraction video.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Procedural Pain measured with Numeric Rating Scale (NRS; scale 0-10; higher score stating higher levels of pain)
Time Frame: pre-, peri-, post-interventional (before puncture when entering intervention room, during puncture and 5 minutes after puncture)
Virtual Reality vs. Standard-of-Care
pre-, peri-, post-interventional (before puncture when entering intervention room, during puncture and 5 minutes after puncture)
Procedural Anxiety measured with modified Yale Preoperative Anxiety Scale (mYPAS-SF; scale 23-100; higher score stating higher levels of anxiety)
Time Frame: pre-, peri-interventional (before puncture when entering intervention room and during puncture)
Virtual Reality vs. Standard-of-Care
pre-, peri-interventional (before puncture when entering intervention room and during puncture)
Procedural Distress measured with Behavioral Approach Avoidance Distress Scale (BAADS; scale 0-10; higher score stating higher levels of distress)
Time Frame: pre-, peri-interventional (before puncture when entering intervention room and during puncture)
Virtual Reality vs. Standard-of-Care
pre-, peri-interventional (before puncture when entering intervention room and during puncture)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptance of VR in pediatric procedures (questionnaire using a 5-point-likert-scale)
Time Frame: post-interventional (immediately after the intervention)
Parents and patients were given different statements
post-interventional (immediately after the intervention)
Implementation factors for VR in pediatric outpatient clinics (qualitive questionnaire)
Time Frame: through study completion, ~ 1.5 years in total
Involved staff were asked about experience/feedback
through study completion, ~ 1.5 years in total

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Urs Mücke, Dr., Hannover Medical School

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2021

Primary Completion (Actual)

December 20, 2022

Study Completion (Actual)

December 20, 2023

Study Registration Dates

First Submitted

December 23, 2023

First Submitted That Met QC Criteria

January 23, 2024

First Posted (Actual)

February 1, 2024

Study Record Updates

Last Update Posted (Actual)

February 13, 2024

Last Update Submitted That Met QC Criteria

February 9, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe